Updated on 24 June 2013
BioSingapore will also look into driving more regional collaborations for market expansion & co-development opportunities for local start-ups & BMS companies in the region. A directory of profiles of Singaporean companies and their technologies will be put together highlighting opportunities for international collaboration and partnerships. This will enhance the reputation and brand equity of Singaporean Biomedical Sciences companies in the region.
What are the major developments and changes in the field of bioscience that have happened recently in the country?
The biomedical sciences manufacturing output has already increased four-fold from $5 billion (SGD 6 billion) per year in 2000 to $22 billion (SGD 27 billion) in 2011. Furthermore, 22 percent of the total manufacturing value added is derived from biomedical sciences.